Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.-论文-万方医学网

第一作者： Jordi,Rovira

第一单位： Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.;Red de Investigación Renal (REDINREN), Madrid, Spain.

作者： Jordi,Rovira ^[1] ; María José,Ramírez-Bajo ^[2] ; Elisenda,Banon-Maneus ^[2] ; Marta,Lazo-Rodríguez ^[2] ; Daniel,Moya-Rull ^[2] ; Natalia,Hierro-Garcia ^[3] ; Valeria,Tubita ^[3] ; Gastón J,Piñeiro ^[4] ; Ignacio,Revuelta ^[5] ; Pedro,Ventura-Aguiar ^[4] ; David,Cucchiari ^[4] ; Federico,Oppenheimer ^[4] ; Mercè,Brunet ^[6] ; Josep M,Campistol ^[5] ; Fritz,Diekmann ^[5]

作者单位： Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.;Red de Investigación Renal (REDINREN), Madrid, Spain. ^[1] Red de Investigación Renal (REDINREN), Madrid, Spain.;Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Fundació Clínic per la Recerca Biomèdica (FCRB), Barcelona, Spain. ^[2] Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ^[3] Departament de Nefrologia i Trasplantament Renal, Institut Clínic de Nefrologia i Urologia (ICNU), Hospital Clínic de Barcelona, Barcelona, Spain. ^[4] Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.;Red de Investigación Renal (REDINREN), Madrid, Spain.;Departament de Nefrologia i Trasplantament Renal, Institut Clínic de Nefrologia i Urologia (ICNU), Hospital Clínic de Barcelona, Barcelona, Spain. ^[5] Laboratori de Farmacologia i Toxicologia, Servei de Bioquímica i Genètica Molecular, Centre Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. ^[6]

医学主题词动物(Animals);慢性病(Chronic Disease);补体C4b(Complement C4b);疾病模型, 动物(Disease Models, Animal);疾病恶化(Disease Progression);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);免疫, 细胞(Immunity, Cellular);免疫, 体液(Immunity, Humoral);免疫抑制剂(Immunosuppressive Agents);Janus激酶3(Janus Kinase 3);肾(Kidney);肾移植(Kidney Transplantation);男(雄)性(Male);肽碎片(Peptide Fragments);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);吡咯类(Pyrroles);大鼠(Rats);大鼠, 近交F344(Rats, Inbred F344);大鼠, 近交Lew(Rats, Inbred Lew);信号传导(Signal Transduction);治疗结果(Treatment Outcome)

DOI 10.1097/TP.0000000000002204

PMID 29620612

发布时间 2020-06-16

检索历史清除

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Transplantation

相似文献

同项目论文

Transplantation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Transplantation

相似文献

同项目论文

Transplantation

相关期刊

检索历史清除